ProPhase Labs Inc (PRPH) stock price forecast predicts $14 value

A share price of ProPhase Labs Inc [PRPH] is currently trading at $0.43, up 39.02%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PRPH shares have gain 8.90% over the last week, with a monthly amount drifted -19.61%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

ProPhase Labs Inc [NASDAQ: PRPH] stock has seen the most recent analyst activity on December 20, 2021, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $12. Previously, Dawson James downgraded its rating to Neutral on October 13, 2021. On January 20, 2021, Dawson James initiated with a Buy rating and assigned a price target of $25 on the stock.

ProPhase Labs Inc experienced fluctuations in its stock price throughout the past year between $0.22 and $7.48. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. ProPhase Labs Inc [NASDAQ: PRPH] shares were valued at $0.43 at the most recent close of the market. An investor can expect a potential return of 3155.81% based on the average PRPH price forecast.

Analyzing the PRPH fundamentals

Trailing Twelve Months sales for ProPhase Labs Inc [NASDAQ:PRPH] were 12.75M which represents -62.39% decline. Gross Profit Margin for this corporation currently stands at -0.32% with Operating Profit Margin at -2.78%, Pretax Profit Margin comes in at -2.98%, and Net Profit Margin reading is -2.18%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.63 and Total Capital is -0.56. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.78.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3607 points at the first support level, and at 0.2920 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4673, and for the 2nd resistance point, it is at 0.5052.

Ratios To Look Out For

To put it in perspective, the Current Ratio for ProPhase Labs Inc [NASDAQ:PRPH] is 1.47. As well, the Quick Ratio is 1.33, while the Cash Ratio is 0.02. Considering the valuation of this stock, the price to sales ratio is 1.01, the price to book ratio is 0.21.

Related Posts